Search NLS News

Ultimovacs has announced the completion of enrollment of 75 patients and that the last patient has received the first dose in the FOCUS study. “We are pleased to announce the completion of patient enrollment in the FOCUS trial, the third of five randomized Phase II clinical trials evaluating UV1 in different cancer indications and in […]

The European Commission has granted marketing authorization in the European Union (EU) for Ztalmy (ganaxolone) oral suspension for the adjunctive treatment of epileptic seizures associated with cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder (CDD) in patients two to 17 years of age. Ztalmy may be continued in patients 18 years of age and older. CDD is […]

Evaxion Biotech has entered into a binding agreement for a financing of up to 20 million USD with Negma Group Investment. “We are pleased to be able to establish a flexible financing vehicle with Negma Group. The ability to attract such an experienced investor is a tribute to Evaxion’s AI technology and pipeline progress,” says […]

The company has announced that a new formulation patent for the drug candidate cobitolimod has been granted by the European Patent Office. The patent provides protection of the enema formulation of cobitolimod, that is currently under evaluation in the ongoing phase III program CONCLUDE. The patent will provide an exclusivity period until September 2042, with […]

Bavarian Nordic has announced topline results from a randomized, double-blind, placebo-controlled Phase 3 clinical trial of its virus-like particle (VLP)-based chikungunya virus vaccine candidate, CHIKV VLP, in adults and adolescents aged 12 to 64 years of age. A total of 3,254 participants were enrolled and randomized to receive either a single intramuscular injection of CHIKV […]

ADDvise Group has entered into a share purchase agreement with the owners of Diabetic Supplies Inc regarding the acquisition of all shares of Diabetic Supplies. Closing of the acquisition is expected to take place at the beginning of September 2023. Diabetic Supplies’ revenue for the last twelve months per June 30, 2023, amounted to USD […]

Digital twin technology has gained popularity in recent years and has been regarded as a potential solution for life sciences manufacturers looking to predict process conditions. Simply put, digital twins are virtual models that replicate the behavior of a physical asset, process, or product. It’s a concept that has been around for some time, but […]

Chemotherapy is one of the most widely used cancer therapies; however, chemotherapy often causes serious side effects. Antibody-drug conjugates (ADCs) are promisingly emerging cancer therapies that combine the effective killing power of small molecule cytotoxins and the highly specific targeting ability of monoclonal antibodies (mAbs). Thus, ADCs precisely deliver cytotoxins to tumor cells, while minimally […]

Transplantation of modified organs using gene-editing technologies and rebuilding the skin with innovative tissue repair methods could save many lives and restore essential functions in a gentle way. Over the past 50 years transplantation has become a successful worldwide medical practice, with advances including restoring sight in corneal blindness through corneal graft, transplantation of haematopoietic […]

Elos Medtech has entered into an agreement to acquire Klingel Holding from IK Partners and management. Klingel, a leading contract development and manufacturing organization (CDMO) headquartered in Germany, will strengthen Elos Medtech’s position with extraordinary R&D capabilities and new technology expertise, the company states. Further, the acquisition will broaden the product offering and add new […]